Kestra Advisory Services, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1830819
AUSTIN, TX
Position in VRTX
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$7,814,556
+$1,585,323 QoQ
Shares Held
15,732
+12.8% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#407
of 1,735 holders
Holding Since
Sep 2020
24 quarters on record
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kestra Advisory Services, LLC holds $29,012,263 across 51 Biotechnology names. VRTX ranks #1 (26.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
15,732 | $7,814,556 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,893 | $1,803,901 | |
| 3 | RPRX |
Royalty Pharma plc
|
27,331 | $1,532,449 | |
| 4 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
39,421 | $1,239,002 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
27,091 | $1,056,819 | |
| 6 | IBRX |
ImmunityBio, Inc.
|
110,630 | $968,565 | |
| 7 | CORT |
Corcept Therapeutics Inc
|
10,914 | $948,972 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
17,292 | $943,105 |
All Filings in VRTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,814,556 | 15,732 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $6,229,233 | 13,950 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $6,542,438 | 14,431 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,636,091 | 14,391 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,392,181 | 14,358 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $6,404,472 | 13,210 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $6,547,096 | 16,258 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $7,799,856 | 16,771 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $9,254,407 | 19,744 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,544,542 | 20,441 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,330,530 | 18,016 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,484,207 | 15,771 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,386,686 | 15,307 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,842,908 | 12,197 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,343,052 | 21,965 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $5,560,326 | 19,204 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $6,206,706 | 22,026 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $6,366,885 | 24,397 | Shares | Sole | 2022-07-20 | |
| 2021-12-31 | $4,101,469 | 18,677 | Shares | Sole | 2022-07-25 | |
| 2021-09-30 | $3,714,685 | 20,479 | Shares | Sole | 2022-07-25 | |
| 2021-06-30 | $4,596,962 | 22,799 | Shares | Sole | 2022-07-26 | |
| 2021-03-31 | $5,102,992 | 23,747 | Shares | Sole | 2022-07-27 | |
| 2020-12-31 | $1,239,366 | 5,244 | Shares | Sole | 2022-07-28 | |
| 2020-09-30 | $23,402 | 86 | Shares | Sole | 2022-07-29 | |
| No filing history on record for this holder in this stock. | ||||||